Koshinski Asset Management Inc. Has $510,000 Holdings in The Clorox Company (NYSE:CLX)

Koshinski Asset Management Inc. cut its stake in shares of The Clorox Company (NYSE:CLXFree Report) by 15.2% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,331 shares of the company’s stock after selling 599 shares during the period. Koshinski Asset Management Inc.’s holdings in Clorox were worth $510,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in CLX. Fortitude Family Office LLC acquired a new stake in shares of Clorox during the fourth quarter worth $29,000. Venturi Wealth Management LLC grew its stake in shares of Clorox by 308.5% during the first quarter. Venturi Wealth Management LLC now owns 192 shares of the company’s stock worth $29,000 after purchasing an additional 145 shares during the period. Northwest Financial Advisors acquired a new stake in shares of Clorox during the fourth quarter worth $29,000. Core Wealth Advisors Inc. acquired a new stake in shares of Clorox during the fourth quarter worth $29,000. Finally, First United Bank & Trust acquired a new stake in shares of Clorox during the fourth quarter worth $31,000. 78.53% of the stock is owned by institutional investors and hedge funds.

Clorox Price Performance

Clorox stock traded up $0.34 during mid-day trading on Friday, reaching $136.65. 94,181 shares of the company were exchanged, compared to its average volume of 1,229,269. The company has a fifty day simple moving average of $134.36 and a 200-day simple moving average of $143.02. The Clorox Company has a 12 month low of $114.68 and a 12 month high of $169.14. The company has a debt-to-equity ratio of 9.73, a current ratio of 0.90 and a quick ratio of 0.53. The firm has a market cap of $16.97 billion, a PE ratio of 70.63, a PEG ratio of 2.04 and a beta of 0.39.

Clorox (NYSE:CLXGet Free Report) last issued its quarterly earnings results on Tuesday, April 30th. The company reported $1.71 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.33 by $0.38. Clorox had a return on equity of 302.49% and a net margin of 3.33%. The company had revenue of $1.81 billion for the quarter, compared to analyst estimates of $1.87 billion. During the same quarter last year, the company posted $1.51 EPS. The company’s revenue for the quarter was down 5.3% compared to the same quarter last year. As a group, equities research analysts expect that The Clorox Company will post 5.91 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on CLX. BNP Paribas began coverage on Clorox in a report on Monday, June 24th. They issued an “underperform” rating and a $130.00 price target on the stock. DA Davidson restated a “neutral” rating and issued a $162.00 price target on shares of Clorox in a report on Wednesday, April 17th. Barclays dropped their target price on Clorox from $136.00 to $132.00 and set an “underweight” rating on the stock in a report on Thursday, May 2nd. JPMorgan Chase & Co. dropped their target price on Clorox from $159.00 to $158.00 and set a “neutral” rating on the stock in a report on Wednesday, May 1st. Finally, Deutsche Bank Aktiengesellschaft dropped their target price on Clorox from $155.00 to $151.00 and set a “hold” rating on the stock in a report on Wednesday, April 17th. Five equities research analysts have rated the stock with a sell rating and fourteen have issued a hold rating to the company. According to data from MarketBeat, Clorox currently has a consensus rating of “Hold” and an average target price of $144.67.

Check Out Our Latest Stock Analysis on Clorox

Clorox Company Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

See Also

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.